FBXL2 and lung adenocarcinoma: Moreover, clinical analyses of TCGA database revealed low expression of FBXL2 and high expression of Grp94 in lung adenocarcinoma (LUAD) or lung squamous cell carcinoma (LUSC) (Supplementary Fig. 6b, c).